FDA Import Refusal 799-3180041-2/11/1 — Abbvie Corporation
The FDA refused shipment 799-3180041-2/11/1 from Abbvie Corporation (Canada) on Oct 4, 2024. The refused product falls under Drugs and Biologics — UPADACITINIB (ANTI-RHEUMATIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Oct 4, 2024
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 62QCY06 UPADACITINIB (ANTI-RHEUMATIC)
- Charges
- 75